CN102313803A - Goat pox indirect hemagglutination diagnosis reagent as well as preparation method and detecting method thereof - Google Patents
Goat pox indirect hemagglutination diagnosis reagent as well as preparation method and detecting method thereof Download PDFInfo
- Publication number
- CN102313803A CN102313803A CN201110166920A CN201110166920A CN102313803A CN 102313803 A CN102313803 A CN 102313803A CN 201110166920 A CN201110166920 A CN 201110166920A CN 201110166920 A CN201110166920 A CN 201110166920A CN 102313803 A CN102313803 A CN 102313803A
- Authority
- CN
- China
- Prior art keywords
- goat pox
- red blood
- diagnostic reagent
- virus antigen
- pox virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种山羊痘正向间接血凝诊断试剂及其制备方法和检测方法,该血凝诊断试剂中山羊痘病毒抗原致敏红细胞的含量为0.6~1.2%,纯化山羊痘病毒抗原含量为20~200μg/ml,与现有常用的琼脂扩散实验相比,本发明以纯化山羊痘病毒抗原致敏醛化绵羊红细胞制备了山羊痘正向间接血凝诊断试剂,可快速、准确、简便的检测山羊痘病毒抗体,在50分钟内即可判定结果,并且能检测出较低效价的抗体,具有较好的特异性、敏感性和可重复性,可广泛应用于兽医临床上山羊痘病毒抗体的快速、大量检测,为疾病预防、诊断和防控提供依据。The invention discloses a goat pox forward indirect hemagglutination diagnostic reagent and a preparation method and a detection method thereof. The goat pox virus antigen-sensitized red blood cell content in the hemagglutination diagnostic reagent is 0.6-1.2%, and the purified goat pox virus antigen content is Compared with the existing commonly used agar diffusion test, the present invention prepares goat pox positive indirect hemagglutination diagnostic reagent by purifying goat pox virus antigen sensitized aldehydated sheep red blood cells, which can be fast, accurate and simple The detection of goat pox virus antibody can be judged within 50 minutes, and can detect antibodies with lower titer, which has good specificity, sensitivity and repeatability, and can be widely used in veterinary clinical goat pox The rapid and large-scale detection of virus antibodies provides a basis for disease prevention, diagnosis, and prevention and control.
Description
技术领域 technical field
本发明涉及正向血凝诊断试剂技术领域,特别是涉及一种山羊痘正向间接血凝诊断试剂及其制备方法和检测方法。 The invention relates to the technical field of positive hemagglutination diagnostic reagents, in particular to a goat pox forward indirect hemagglutination diagnostic reagent and a preparation method and a detection method thereof.
背景技术 Background technique
山羊痘是由山羊痘病毒属山羊痘病毒(goat poxvirus,GTPV)引起的一种呈地方流行的高度接触性传染病,一年四季均可发生,春秋常见,不分性别、年龄、品种。世界动物卫生组织(OIE)将山羊痘列为A类重大传染病,1999年中华人民共和国农业部第96号公告将山羊痘列为国家一类动物疫病。近年来,我国二十多个省市相继报导山羊痘发生流行,给我国蓬勃兴起的山羊养殖业造成了极大的经济损失,带来了严峻威胁。传统的检测山羊痘的方法可采用琼脂扩散法,但该方法的灵敏度不高、检测速度较慢。 Goat pox is an endemic highly contagious infectious disease caused by goat poxvirus (GTPV), which can occur all year round and is common in spring and autumn, regardless of gender, age, or species. The World Organization for Animal Health (OIE) listed goat pox as a major infectious disease of category A, and in 1999, the Ministry of Agriculture of the People's Republic of China announced goat pox as a national first-class animal disease. In recent years, more than 20 provinces and cities in my country have successively reported the occurrence of goat pox epidemic, which has caused great economic losses and posed a serious threat to the booming goat breeding industry in my country. The traditional method for detecting goat pox can be agar diffusion method, but the sensitivity of this method is not high and the detection speed is slow.
发明内容 Contents of the invention
本发明所要解决的技术问题是克服现有检测山羊痘疾病的方法的灵敏度不高、检测速度较慢的缺陷,提供一种山羊痘正向间接血凝诊断试剂及其制备方法,该试剂可敏感、快速、准确、简便的检测山羊痘病毒抗体。 The technical problem to be solved by the present invention is to overcome the defects of low sensitivity and slow detection speed of the existing methods for detecting goat pox disease, and provide a diagnostic reagent for goat pox positive indirect hemagglutination and a preparation method thereof. , Rapid, accurate and simple detection of goat pox virus antibody.
为了解决上述技术问题,本发明采用如下的技术方案: In order to solve the problems of the technologies described above, the present invention adopts the following technical solutions:
本发明山羊痘正向间接血凝诊断试剂中山羊痘病毒抗原致敏红细胞的含量为0.6~1.2%(体积),纯化山羊痘病毒抗原含量为20~200μg/ml。 The goat pox virus antigen-sensitized red blood cell content in the goat pox positive indirect hemagglutination diagnostic reagent of the present invention is 0.6-1.2% (volume), and the purified goat pox virus antigen content is 20-200 μg/ml.
优选的,上述血凝诊断试剂中山羊痘病毒抗原致敏红细胞的含量为0.8~1%,纯化山羊痘病毒抗原含量为100μg /ml。 Preferably, the content of goat pox virus antigen-sensitized erythrocytes in the above-mentioned hemagglutination diagnostic reagent is 0.8-1%, and the content of purified goat pox virus antigen is 100 μg/ml.
前述山羊痘正向间接血凝诊断试剂中的致敏红细胞是用纯化山羊痘病毒抗原致敏的醛化绵羊红细胞。 The sensitized erythrocytes in the goat pox positive indirect hemagglutination diagnostic reagent are the alkylated sheep erythrocytes sensitized with purified goat pox virus antigen.
本发明还提供了一种制备前述山羊痘正向间接血凝诊断试剂的方法:采集健康绵羊静脉血,制备成红细胞悬液,用戊二醛进行醛化,用纯化山羊痘病毒抗原致敏,离心分离,取沉淀红细胞配制成红细胞悬液,经血凝检测合格后即得。 The present invention also provides a method for preparing the above-mentioned goat pox forward indirect hemagglutination diagnostic reagent: collect healthy sheep venous blood, prepare red blood cell suspension, carry out hydroformylation with glutaraldehyde, sensitize with purified goat pox virus antigen, After centrifugation, the precipitated erythrocytes are taken to prepare erythrocyte suspension, which is obtained after passing the hemagglutination test.
进一步的,上述方法为:采集健康绵羊静脉血,用PBS离心分离提取红细胞,再用磷酸缓冲液制备成红细胞悬液,用戊二醛醛化,离心分离得醛化红细胞,用纯化山羊痘病毒抗原致敏,离心分离,取沉淀红细胞用含NaN3和新生犊牛血清的磷酸缓冲液洗涤,再用此缓冲液配制成红细胞悬液,经血凝检测合格后即得。 Further, the above method is as follows: collect venous blood from healthy sheep, extract erythrocytes by centrifugation with PBS, prepare erythrocyte suspension with phosphate buffer, formaldehydeylate with glutaraldehyde, and centrifuge to obtain erythrocytes, and use purified goat pox virus Antigen sensitization, centrifugal separation, the precipitated red blood cells are washed with phosphate buffer containing NaN 3 and newborn calf serum, and then the buffer is used to prepare red blood cell suspension, which is obtained after passing the hemagglutination test.
最佳的,前述制备方法为:采集健康绵羊静脉血,用PBS离心分离提取红细胞,再用0.1M、pH7.4的磷酸缓冲液制备成2.5%(体积)的红细胞悬液,用戊二醛醛化后离心分离,用0.1M、pH7.4的磷酸缓冲液的洗涤得醛化红细胞,将醛化红细胞溶于10体积倍量的0.1M、 pH 7.4的磷酸缓冲液中,再与等体积量纯化山羊痘病毒抗原混合,于室温条件下搅拌2h致敏,离心分离,取沉淀红细胞用含0.1%(质量)NaN3和1%(体积)新生犊牛血清的0.1M、pH7.4磷酸缓冲液洗涤,再用此缓冲液配制成红细胞悬液,经血凝检测合格后即得。 Optimally, the aforementioned preparation method is as follows: collect venous blood from healthy sheep, extract red blood cells by centrifugation with PBS, then prepare a 2.5% (volume) red blood cell suspension with 0.1M, pH7.4 phosphate buffer, and use glutaraldehyde Centrifuge after hydroformylation, wash with 0.1M, pH 7.4 phosphate buffer to obtain formaldehyde erythrocytes, dissolve 10 times the volume of 0.1M, pH 7.4 phosphate buffer, and then mix with an equal volume Quantitatively purified goat pox virus antigens were mixed, stirred at room temperature for 2 hours for sensitization, centrifuged, and the precipitated red blood cells were washed with 0.1M, pH7.4 phosphoric acid solution containing 0.1% (mass) NaN 3 and 1% (volume) newborn calf serum. After washing with the buffer solution, the red blood cell suspension is prepared with the buffer solution, and obtained after passing the hemagglutination test.
采用前述诊断试剂检测山羊痘的方法:检测时,pH值控制在7.4~7.8,反应温度20~25℃,反应时间50min。 The method for detecting goat pox with the aforementioned diagnostic reagents: during detection, the pH value is controlled at 7.4-7.8, the reaction temperature is 20-25° C., and the reaction time is 50 minutes.
与现有常用的琼脂扩散实验相比,本发明以纯化山羊痘病毒抗原致敏醛化绵羊红细胞制备了山羊痘正向间接血凝诊断试剂,可快速、准确、简便的检测山羊痘病毒抗体,在50分钟内即可判定结果,并且能检测出较低效价的抗体,具有较好的特异性、敏感性和可重复性,可广泛应用于兽医临床上山羊痘病毒抗体的快速、大量检测,为疾病预防、诊断和防控提供依据。 Compared with the existing commonly used agar diffusion test, the present invention prepares goat pox positive indirect hemagglutination diagnostic reagent by purifying goat pox virus antigen sensitized and aldehylated sheep erythrocytes, which can detect goat pox virus antibody quickly, accurately and easily. The results can be judged within 50 minutes, and antibodies with lower titers can be detected. It has good specificity, sensitivity and repeatability, and can be widely used in the rapid and large-scale detection of goat pox virus antibodies in veterinary clinics. , to provide a basis for disease prevention, diagnosis and control.
具体实施方式 Detailed ways
山羊痘反向间接血凝诊断试剂按如下配比和方法制备 Goat pox reverse indirect hemagglutination diagnostic reagent is prepared according to the following ratio and method
1、制备醛化红细胞 1. Preparation of aldylated red blood cells
无菌采集健康绵羊静脉血,加10体积倍PBS,2000转/分离心15分钟,用PBS洗5遍,以磷酸缓冲液(0.1M,pH 7.4)配成2.5%(体积)的红细胞悬液,然后将此红细胞悬液与1%(体积)戊二醛水溶液以9:1的体积比混合,于室温下缓慢搅拌1h,2000 转/分离心15分钟,用磷酸缓冲液洗5遍,得醛化沉淀红细胞。 Aseptically collect venous blood from healthy sheep, add 10 times the volume of PBS, centrifuge at 2000 rpm for 15 minutes, wash 5 times with PBS, and prepare 2.5% (volume) red blood cell suspension with phosphate buffer (0.1M, pH 7.4) , and then mix this erythrocyte suspension with 1% (volume) glutaraldehyde aqueous solution at a volume ratio of 9:1, stir slowly at room temperature for 1 hour, centrifuge at 2000 rpm for 15 minutes, and wash 5 times with phosphate buffer solution to obtain Aldehydization precipitates red blood cells.
2、致敏:将醛化沉淀红细胞溶于10体积倍磷酸缓冲液(0.1M, pH 7.4)中,再与等体积量纯化山羊痘病毒抗原混合,于室温下搅拌2h,2000转/分离心15分钟,得沉淀致敏红细胞。 2. Sensitization: Dissolve the formaldehyde-precipitated erythrocytes in 10 times the volume of phosphate buffer (0.1M, pH 7.4), mix with an equal volume of purified goat pox virus antigen, stir at room temperature for 2 hours, and centrifuge at 2000 rpm After 15 minutes, the precipitated sensitized red blood cells were obtained.
3、取沉淀致敏红细胞用含0.1%(重量)NaN3、1%(体积)新生犊牛血清的磷酸缓冲液(0.1M,pH 7.4)洗涤5次,然后配成致敏红细胞浓度1%(体积)、病毒抗原含量100μg/ml的红细胞悬液。 3. Wash the precipitated sensitized red blood cells with phosphate buffer (0.1M, pH 7.4) containing 0.1% (weight) NaN3 and 1% (volume) newborn calf serum for 5 times, and then make the concentration of sensitized red blood cells 1% ( volume), red blood cell suspension with viral antigen content of 100 μg/ml.
4、按常规反向间接血凝试验方法分析检测合格后即制得反向间接血凝诊断试剂。 4. According to the conventional reverse indirect hemagglutination test method, the reverse indirect hemagglutination diagnostic reagent is prepared after passing the analysis and testing.
检测时,pH值控制在7.4~7.8,反应温度20~25℃,反应时间50min为最佳反应条件。 During detection, the pH value is controlled at 7.4-7.8, the reaction temperature is 20-25° C., and the reaction time is 50 minutes, which are the optimal reaction conditions.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110166920A CN102313803A (en) | 2011-06-21 | 2011-06-21 | Goat pox indirect hemagglutination diagnosis reagent as well as preparation method and detecting method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110166920A CN102313803A (en) | 2011-06-21 | 2011-06-21 | Goat pox indirect hemagglutination diagnosis reagent as well as preparation method and detecting method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102313803A true CN102313803A (en) | 2012-01-11 |
Family
ID=45427148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110166920A Pending CN102313803A (en) | 2011-06-21 | 2011-06-21 | Goat pox indirect hemagglutination diagnosis reagent as well as preparation method and detecting method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102313803A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101460627A (en) * | 2006-06-20 | 2009-06-17 | 特朗斯吉有限公司 | Process for producing poxviruses and poxvirus compositions |
| WO2011003194A1 (en) * | 2009-07-10 | 2011-01-13 | The Governors Of The University Of Alberta | Oncolytic viruses and methods for treating neoplastic disorders |
-
2011
- 2011-06-21 CN CN201110166920A patent/CN102313803A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101460627A (en) * | 2006-06-20 | 2009-06-17 | 特朗斯吉有限公司 | Process for producing poxviruses and poxvirus compositions |
| WO2011003194A1 (en) * | 2009-07-10 | 2011-01-13 | The Governors Of The University Of Alberta | Oncolytic viruses and methods for treating neoplastic disorders |
Non-Patent Citations (1)
| Title |
|---|
| 刘忠伟: "山羊痘病毒的血清学检测与PCR鉴定", 《中国优秀博硕士学位论文数据库(硕士)农业科技辑》, no. 11, 15 November 2006 (2006-11-15) * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101712971B (en) | Mycoplasma capricolum subsp. pneumonia antigen of goats and preparation method thereof | |
| CN103344772B (en) | Novel Miltenberger blood group antibody detecting method | |
| CN105067812A (en) | Bovine brucella indirect ELISA antibody detection kit | |
| CN106771182A (en) | Brucella abortus IgM subclass antibodies indirect ELISA testing kits | |
| CN105675866B (en) | For detecting that the solid phase of O-shaped FMDV antibody blocks ELISA kit | |
| JP2009537013A (en) | Antigen capture anti-dengue IgA ELISA (ACA-ELISA) for detection of flavivirus specific antibodies | |
| CN101592660B (en) | Brucellosis indirect enzyme-linked immunosorbent assay milk liquid antibody reagent kit | |
| CN110567861A (en) | Kit and detection method for screening immunogenic antigen peptides based on mass spectrometry flow detection technology | |
| CN109298175A (en) | A kind of feline parvovirus antibody ELISA kit and detection method thereof | |
| CN104569386A (en) | Tilapia source streptococcus agalactiae ELISA rapid detection kit and detection method thereof | |
| CN106153893A (en) | The enzyme-linked immunologic detecting kit of saliva anti-mitochondrial antibody M2 type | |
| CN102368068B (en) | Kit for detecting chlamydia pneumoniae IgM antibody | |
| CN102253197A (en) | Goat pox reverse indirect blood coagulation diagnostic reagent, and preparation method, and detection method thereof | |
| CN101368964A (en) | Chemical luminescence method immune analysis diagnostic reagent kit for detecting cytomegalovirus IgG antibody | |
| CN105738624B (en) | A kind of indirect immunofluorescene assay method of Rift Valley fever virus IgG antibody | |
| CN102313803A (en) | Goat pox indirect hemagglutination diagnosis reagent as well as preparation method and detecting method thereof | |
| CN104155444A (en) | ELISA kit for detecting mycoplasma capricolum subsp.capripneumoniae antibody and preparation method thereof | |
| CN104502588A (en) | ELISA kit for detecting canine distemper virus IgG antibody and preparation method of ELISA kit | |
| JP7489228B2 (en) | SARS-CoV-2 derived nucleocapsid fragment and method and kit for detecting anti-SARS-CoV-2 antibodies using said fragment | |
| CN107064488A (en) | A kind of total antibody solid phase of CSFV serum blocks the preparation method of antigen used in ELISA kit | |
| CN102433339B (en) | HCV Nucleic acid aptamer and application thereof in preparing HCV-cAg detection kit | |
| CN102288768A (en) | Toxoplasma gondii IgG (immunoglobulin G) antibody immunoblotting kit and preparation method thereof | |
| CN102360012A (en) | Immunochromatography detection reagent strip for combined detection of toxoplasmagondii IgG antibodies and total antibodies, and preparation method thereof | |
| CN202256347U (en) | Toxoplasma gondii IgM antibody and total antibody combined detection reagent strip | |
| CN102288756A (en) | Preparation method and detection method of goat pox reverse indirect hemagglutination diagnostic reagent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120111 |